You are here > News and publications

News and publications

Promethera Biosciences strengthens and completes its management team with two key senior appointments

01/12/2015

Mont-Saint-Guibert, Belgium, 01 December, 2015 – Promethera Biosciences, a Belgian biotechnology company developing stem cell therapies for the treatment of inborn errors of metabolism and acquired liver diseases, today announces two senior appointments. Dr Jürgen Beck has been appointed as VP Clinical and Medical Affairs and Patrick Stragier as VP Operations.

 

Download this file (FR)

Download this file (EN)

 

 

Contacts

PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
(Belgium)
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea